Cargando…

The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis

BACKGROUND: Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuzhen, Wang, Lei, Zhang, Jing, An, Wei, Jia, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982199/
https://www.ncbi.nlm.nih.gov/pubmed/33725984
http://dx.doi.org/10.1097/MD.0000000000025080
_version_ 1783667669480767488
author Zhang, Shuzhen
Wang, Lei
Zhang, Jing
An, Wei
Jia, Li
author_facet Zhang, Shuzhen
Wang, Lei
Zhang, Jing
An, Wei
Jia, Li
author_sort Zhang, Shuzhen
collection PubMed
description BACKGROUND: Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined with leuprorelin acetate is effective in the treatment of EMS, which can relieve perimenopausal symptoms, but it lacks of evidence-based medical evidence. Therefore, this study aims to systematically evaluate the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. METHODS: CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, The Cochrance Library, Embase, Web of Science, and other databases were searched by computer to collect randomized controlled trials of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. The retrieval time was from the establishment of the database to February 2021. Two researchers screened the literatures and extracted the data and meta-analysis was performed using RevMan 5.3 software. RESULTS: This study evaluated the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS by clinical effective rate, serum sex hormone levels estradiol, follicle-stimulating hormone, luteinizing hormone, visual analogue scale, Kupperman score and incidence of adverse reactions. CONCLUSION: This study will provide reliable evidence-based evidence for the clinical application of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. ETHICS AND DISSEMINATION: Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/AZU47
format Online
Article
Text
id pubmed-7982199
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-79821992021-03-23 The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis Zhang, Shuzhen Wang, Lei Zhang, Jing An, Wei Jia, Li Medicine (Baltimore) 3800 BACKGROUND: Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined with leuprorelin acetate is effective in the treatment of EMS, which can relieve perimenopausal symptoms, but it lacks of evidence-based medical evidence. Therefore, this study aims to systematically evaluate the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. METHODS: CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, The Cochrance Library, Embase, Web of Science, and other databases were searched by computer to collect randomized controlled trials of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. The retrieval time was from the establishment of the database to February 2021. Two researchers screened the literatures and extracted the data and meta-analysis was performed using RevMan 5.3 software. RESULTS: This study evaluated the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS by clinical effective rate, serum sex hormone levels estradiol, follicle-stimulating hormone, luteinizing hormone, visual analogue scale, Kupperman score and incidence of adverse reactions. CONCLUSION: This study will provide reliable evidence-based evidence for the clinical application of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. ETHICS AND DISSEMINATION: Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/AZU47 Lippincott Williams & Wilkins 2021-03-19 /pmc/articles/PMC7982199/ /pubmed/33725984 http://dx.doi.org/10.1097/MD.0000000000025080 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Zhang, Shuzhen
Wang, Lei
Zhang, Jing
An, Wei
Jia, Li
The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
title The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
title_full The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
title_fullStr The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
title_full_unstemmed The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
title_short The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
title_sort efficacy and safety of kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: a protocol for systematic review and meta-analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982199/
https://www.ncbi.nlm.nih.gov/pubmed/33725984
http://dx.doi.org/10.1097/MD.0000000000025080
work_keys_str_mv AT zhangshuzhen theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT wanglei theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT zhangjing theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT anwei theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT jiali theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT zhangshuzhen efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT wanglei efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT zhangjing efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT anwei efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis
AT jiali efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis